Clinical Trial

The NOrwegian Tick-borne Encephalitis Study

Study acronym: NOTES
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
During 2018, 2019, and 2020, the reported TBE-cases have increased markedly in Norway. Surveillance studies conducted by the Norwegian Institute of Public Health demonstrate that cases are associated with tick bites in the coastal areas of the Agder, Buskerud, and Vestfold and Telemark counties There is a urgent need for more knowledge of the consequences of TBE in Norway, in particular the identification of patients at risk of long-term sequela. Hence, the overall objective of this project is to gain more knowledge about the natural course of TBE in Norway, and its impact on long-term health-related quality of life and associated factors. Clinical data, biological sampling and PROMs are collected from TBE-infected patients admitted to three hospitals within the epidemic region in Norway.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-11-26; most recent amendment 2024-09-23.
Status change: Recruiting → Active, Not Recruiting 2024-09-23
Trial Details
NCT Number NCT05138055
Lead Sponsor Sykehuset Telemark
Collaborators: Sykehuset i Vestfold HF, Norwegian Institute of Public Health, Sorlandet Hospital HF, Oslo University Hospital
Conditions Tick-Borne Encephalitis, European
Enrollment 153 participants
Start Date 2020-10-01
Primary Completion 2023-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-25